Novartis Investigative Site

Tiel 4002 WP

0 studies enrolling now · 2 studies all time

What they study most

Atherosclerosis, Cardiovascular Disease, Type 2 Diabetes Mellitus

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early